ArticleClinical and translational radiation oncology2026

Pre-PROTO-PRIME: stereotactic body proton therapy to the prostate and pelvic nodes for high-risk and node-positive prostate cancer - feasibility, acute toxicity and dosimetric insights.

Srinivas Chilukuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.